Keywords: CEVEC Pharma, Yuhan Corp, Technology license, Therapeutic proteins, South Korea

CEVEC Pharma signs deal with South Korea's Yuhan

Article | 20 December 2012

CEVEC Pharmaceuticals, a German developer of a novel human expression system derived from amniocytes, and Yuhan Corp, a leading manufacturer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in